BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27367594)

  • 1. Pattern and Predictors of Medication Dosing Errors in Chronic Kidney Disease Patients in Pakistan: A Single Center Retrospective Analysis.
    Saleem A; Masood I
    PLoS One; 2016; 11(7):e0158677. PubMed ID: 27367594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.
    Farag A; Garg AX; Li L; Jain AK
    Am J Kidney Dis; 2014 Mar; 63(3):422-8. PubMed ID: 24189475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern, frequency and factors associated with inappropriate high dosing in chronic kidney disease patients at a tertiary care hospital in Pakistan.
    Hayat M; Ahmad N; Khan SLA; Mohkumuddin S; Siddique W; Khan A; Atif M
    BMC Nephrol; 2023 May; 24(1):118. PubMed ID: 37127612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Medication Dosage Adjustment in Hospitalized Patients With Chronic Kidney Disease.
    Hassan Z; Ali I; Ullah AR; Ahmed R; Zar A; Ullah I; Rehman S; Khan AU; Ullah R; Hanif M
    Cureus; 2021 Feb; 13(2):e13449. PubMed ID: 33767933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication treatment complexity and adherence in children with CKD.
    Blydt-Hansen TD; Pierce CB; Cai Y; Samsonov D; Massengill S; Moxey-Mims M; Warady BA; Furth SL
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):247-54. PubMed ID: 24262500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency and nature of medication errors in hospitalized patients with acute coronary syndrome.
    Ali MAS; Lobos CM; Abdelmegid MAF; El-Sayed AM
    Int J Clin Pharm; 2017 Jun; 39(3):542-550. PubMed ID: 28374341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study.
    Baek SD; Baek CH; Kim JS; Kim SM; Kim JH; Kim SB
    Scand J Urol Nephrol; 2012 Jun; 46(3):232-8. PubMed ID: 22545920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease referral practices among non-nephrology specialists: A single-centre experience.
    Buttigieg J; Mercieca L; Saliba A; Aquilina S; Farrugia E; Fava S
    Eur J Intern Med; 2016 Apr; 29():93-7. PubMed ID: 26809863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CKD stage at nephrology referral and factors influencing the risks of ESRD and death.
    Sud M; Tangri N; Levin A; Pintilie M; Levey AS; Naimark DM
    Am J Kidney Dis; 2014 Jun; 63(6):928-36. PubMed ID: 24485146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient impact of automated glomerular filtration rate reporting on drug dosing for hospitalized older adults with concealed renal insufficiency.
    Kalender-Rich JL; Mahnken JD; Wetmore JB; Rigler SK
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):320-7. PubMed ID: 21920825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of symptoms of depression with progression of CKD.
    Tsai YC; Chiu YW; Hung CC; Hwang SJ; Tsai JC; Wang SL; Lin MY; Chen HC
    Am J Kidney Dis; 2012 Jul; 60(1):54-61. PubMed ID: 22495469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CKD and Its Risk Factors among Patients with Cystinuria.
    Prot-Bertoye C; Lebbah S; Daudon M; Tostivint I; Bataille P; Bridoux F; Brignon P; Choquenet C; Cochat P; Combe C; Conort P; Decramer S; Doré B; Dussol B; Essig M; Gaunez N; Joly D; Le Toquin-Bernard S; Méjean A; Meria P; Morin D; N'Guyen HV; Noël C; Normand M; Pietak M; Ronco P; Saussine C; Tsimaratos M; Friedlander G; Traxer O; Knebelmann B; Courbebaisse M;
    Clin J Am Soc Nephrol; 2015 May; 10(5):842-51. PubMed ID: 25717071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-related problems among adult chronic kidney disease patients in a sub-Saharan tertiary hospital.
    Njeri LW; Ogallo WO; Nyamu DG; Opanga SA; Birichi AR
    Int J Clin Pharm; 2018 Oct; 40(5):1217-1224. PubMed ID: 29766391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially preventable hospitalization as a complication of CKD: a cohort study.
    Wiebe N; Klarenbach SW; Allan GM; Manns BJ; Pelletier R; James MT; Bello A; Hemmelgarn BR; Tonelli M;
    Am J Kidney Dis; 2014 Aug; 64(2):230-8. PubMed ID: 24731738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevancy and determinants of potential drug-drug interactions in chronic kidney disease patients: results from a retrospective analysis.
    Saleem A; Masood I; Khan TM
    Integr Pharm Res Pract; 2017; 6():71-77. PubMed ID: 29354553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and Knowledge Among Internal Medicine Resident Trainees for Dose Adjustment of Analgesics and Neuropsychotropic Medications in CKD.
    Saad CY; Fogel J; Rubinstein S
    South Med J; 2018 Mar; 111(3):155-162. PubMed ID: 29505650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgery.
    Satasivam P; Reeves F; Rao K; Ivey Z; Basto M; Yip M; Roth H; Grummet J; Goad J; Moon D; Murphy D; Appu S; Lawrentschuk N; Bolton D; Kearsley J; Costello A; Frydenberg M
    BJU Int; 2015 Oct; 116(4):590-5. PubMed ID: 25676543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between plasma soluble RAGE and renal function is unaffected by medication usage and enzymatic antioxidants in chronic kidney disease with type 2 diabetes.
    Wong FN; Tan JA; Keng TC; Ng KP; Chua KH; Kuppusamy UR
    Clin Chim Acta; 2016 Jan; 453():56-61. PubMed ID: 26657980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.